By Product Type (Tear stimulators, Artificial tears, Secretagogue, Others), Dosage Type (Liquid, Semi-solid, Others), Drug Class (Lubricating Agent, Cholinergics, Anti-Inflammatory, Anti-Infectives, Anti-Allergics, Others), Dose(Unit dose, Multi-dose), Medication Type( Prescription (Rx) Drugs, Over The Counter (OTC) Drugs), Container Type (Unit-Dose Vials, Bottles, Tubes), Packaging Type (Plastic, Aluminium, Glass), Type (Brands, Generics), End Users (Home Healthcare, Hospitals, Clinics, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026" />

Global Dry Eye Syndrome Market – Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Published Report
  • Jul 2019
  • Global
  • 350 Pages
  • No of Tables: 475
  • No of Figures: 58

Global Dry Eye Syndrome Market By Product Type (Tear stimulators, Artificial tears, Secretagogue, Others), Dosage Type (Liquid, Semi-solid, Others), Drug Class (Lubricating Agent, Cholinergics, Anti-Inflammatory, Anti-Infectives, Anti-Allergics, Others), Dose(Unit dose, Multi-dose), Medication Type( Prescription (Rx) Drugs, Over The Counter (OTC) Drugs), Container Type (Unit-Dose Vials, Bottles, Tubes), Packaging Type (Plastic, Aluminium, Glass), Type (Brands, Generics), End Users (Home Healthcare, Hospitals, Clinics, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026

Dry eye is a multifactorial disease of the tears and ocular surface that causes symptoms of disquiet visual disturbance and tears film variability with possible damage to the ocular surface. It is escorted increase in tear film Osmolality and ocular surface inflammation which may result in substantial damage of eye. The symptoms of dry eye syndrome includes eye redness, blurred vision and eye fatigue, watery eyes, which is the body's response to the irritation of dry eyes such as stinging burning and scratchy sensation in eyes.

Global dry eye syndrome market is projected to register a healthy CAGR of 6.8% in the forecast period 2019 to 2026.

Segmentation: Global Dry Eye Syndrome Market

Global dry eye syndrome market is segmented into ten notable segments which are product type, dosage type, drug class, dose, medication type, container type, packaging type, type, end user and distribution channel.

  •          On the basis of product type, the market is segmented into tear stimulators, artificial tears, secretagogue and others
  •         On the basis of dosage type, the market is segmented into liquid, semi solid and others
  •          On the basis of drug class, the market is segmented into anti-inflammatory, lubricating agents, anti-infectives, anti-allergics, cholinergics and others
  •          On the basis of dose, the market is segmented into multi dose and unit dose On the basis of medication type, the market is segmented into prescription (RX) drugs, and over the counter (OTC) drugs
  •         On the basis of container Type, the market is segmented into unit dose vials, bottles, and tubes
  •          On the basis of packaging type, the market is segmented into plastic, glass, and aluminium
  •          On the basis of type, the market is segmented into generics and brands
  •          On the basis of end user, the market is segmented into home healthcare, hospitals, clinics, and others
  •          On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others

Competitive Analysis: Global Dry Eye Syndrome Market

Some of the major players operating in the global dry eye syndrome market are Allergan, Bausch & Lomb Incorporated, Novartis Ag, Johnson & Johnson Services, Inc., Prestige Consumer Healthcare, Inc., Akorn, Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Novaliq Gmbh, Santen Pharmaceutical Co., Ltd., Cardinal Health, Alembic Pharmaceuticals Limited., Cipla Inc., Perrigo Company Plc, Senju Pharmaceutical Co. Ltd., Horus Pharma, Rohto Pharmaceutical Co., Ltd., Visufarma, Hubrx and others.

Product Launch

  •          In November 2018, ROHTO Pharma (India) Private Limited subsidiary of Rohto Pharmaceutical Co., Ltd has launched its Cooling Eye Drops range in India. This drug will help to treat dry eyes disease. It is having cooling formula relief in eye redness and irritated eyes .The major advantage of this launch is that it will help to grow eye care market as ROHTO Cooling Eye Drops was No. 1 OTC eye drop brand in global market and listed in Guinness World Record 2014
  •          In June 2018, Bausch & Lomb announced the launch of Soothe Xtra Protection (XP) Preservative Free lubricant eye drops by expanding the portfolio of the eye health products to meet the rising demand of dry eye symptoms relief without the usage of the preservatives. This will help the company to expand its product portfolio in the market
  •          In May 2018, Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd, launched Teva-Cyclosporine. It is a generic version of Allergen’s Restasis. The major advantage of this product launch is that it will help the company in growing its market share in the dry eye treatment as more than 29.0 % of Canada population suffers from the dry eye syndrome

Research Methodology : Global Dry Eye Syndrome Market

Primary Respondents:

Key Opinion Leaders (KOL’s): Manufacturers, Researchers, Distributors, Bakers and Food Industrialists.

Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and National Sales Managers.

 


SKU-

TABLE 1 AGEING WORLD POPULATION

TABLE 2 GLOBAL DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 3 GLOBAL TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 4 GLOBAL DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 5 GLOBAL DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2016-2026 (USD MILLION)

TABLE 6 GLOBAL LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2016-2026 (USD MILLION)

TABLE 7 GLOBAL LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2016-2026 (USD MILLION)

TABLE 8 GLOBAL SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2016-2026 (USD MILLION)

TABLE 9 GLOBAL DIGITAL IN DRY EYE SYNDROME MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)

TABLE 10 GLOBAL OTHERS IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 11 GLOBAL DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 12 GLOBAL ANTI-INFLAMMATORY IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 GLOBAL LUBRICATING AGENT IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 14 GLOBAL ANTI-INFECTIVE IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 15 GLOBAL ANTI-ALLERGIC IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 16 GLOBAL CHOLINERGIC IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 GLOBAL OTHERS IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 18 GLOBAL DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 19 GLOBAL MULTI DOSE IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 20 GLOBAL UNIT DOSE IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 GLOBAL DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 22 GLOBAL PRESCRIPTION (RX) DRUGS IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 GLOBAL OVER THE COUNTER (OTC) DRUGS IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 24 GLOBAL DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 25 GLOBAL UNIT DOSE VIALS IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 GLOBAL BOTTLES IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 27 GLOBAL TUBES IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 GLOBAL DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 29 GLOBAL PLASTIC IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 GLOBAL GLASS IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 GLOBAL ALUMINUM IN DRY EYE SYNDROME MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 GLOBAL DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 33 GLOBAL GENERICS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 34 GLOBAL BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 35 GLOBAL BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 36 GLOBAL DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 37 GLOBAL HOME HEALTHCARE IN DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 38 GLOBAL HOSPITALS IN DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 39 GLOBAL CLINICS IN DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 40 GLOBAL OTHERS IN DRY EYE SYNDROME MARKET, BY END USER, 2016-2026 (USD MILLION)

TABLE 41 GLOBAL DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 42 GLOBAL HOSPITAL PHARMACY IN DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 43 GLOBAL RETAIL PHARMACY IN DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 44 GLOBAL ONLINE PHARMACY IN DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 45 GLOBAL OTHERS IN DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2016-2026 (USD MILLION)

TABLE 46 GLOBAL DRY EYE SYNDROME MARKET, BY GEOGRAPHY, 2017 – 2026 (USD MILLION)

TABLE 47 NORTH AMERICA DRY EYE SYNDROME MARKET, BY COUNTRY, 2017– 2026 (USD MILLION)

TABLE 48 NORTH AMERICA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 49 NORTH AMERICA TEAR STIMULATORS MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 50 NORTH AMERICA TEAR STIMULATORS MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 51 NORTH AMERICA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 52 NORTH AMERICA SEMI-SOLIDS IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 53 NORTH AMERICA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017– 2026 (USD MILLION)

TABLE 54 NORTH AMERICA DRY EYE SYNDROME MARKET, BY DOSE, 2017– 2026 (USD MILLION)

TABLE 55 NORTH AMERICA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017– 2026 (USD MILLION)

TABLE 56 NORTH AMERICA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017– 2026 (USD MILLION)

TABLE 57 NORTH AMERICA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017– 2026 (USD MILLION)

TABLE 58 NORTH AMERICA DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 59 NORTH AMERICA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 60 NORTH AMERICA DRY EYE SYNDROME MARKET, BY END USER, 2017– 2026 (USD MILLION)

TABLE 61 NORTH AMERICA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017– 2026 (USD MILLION)

TABLE 62 U.S. DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 63 U.S. TEAR STIMULATORS MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 64 U.S. TEAR STIMULATORS MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 65 U.S. LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 66 U.S. SEMI-SOLIDS IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 67 U.S. DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017– 2026 (USD MILLION)

TABLE 68 U.S. DRY EYE SYNDROME MARKET, BY DOSE, 2017– 2026 (USD MILLION)

TABLE 69 U.S. DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017– 2026 (USD MILLION)

TABLE 70 U.S. DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017– 2026 (USD MILLION)

TABLE 71 U.S. DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017– 2026 (USD MILLION)

TABLE 72 U.S. DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 73 U.S. BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 74 U.S. DRY EYE SYNDROME MARKET, BY END USER, 2017– 2026 (USD MILLION)

TABLE 75 U.S. DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017– 2026 (USD MILLION)

TABLE 76 CANADA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 77 CANADA TEAR STIMULATORS MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 78 CANADA TEAR STIMULATORS MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 79 CANADA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 80 CANADA SEMI-SOLIDS IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 81 CANADA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017– 2026 (USD MILLION)

TABLE 82 CANADA DRY EYE SYNDROME MARKET, BY DOSE, 2017– 2026 (USD MILLION)

TABLE 83 CANADA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017– 2026 (USD MILLION)

TABLE 84 CANADA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017– 2026 (USD MILLION)

TABLE 85 CANADA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017– 2026 (USD MILLION)

TABLE 86 CANADA DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 87 CANADA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 88 CANADA DRY EYE SYNDROME MARKET, BY END USER, 2017– 2026 (USD MILLION)

TABLE 89 CANADA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017– 2026 (USD MILLION)

TABLE 90 MEXICO DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 91 MEXICO TEAR STIMULATORS MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 92 MEXICO TEAR STIMULATORS MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 93 MEXICO LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 94 MEXICO SEMI-SOLIDS IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 95 MEXICO DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017– 2026 (USD MILLION)

TABLE 96 MEXICO DRY EYE SYNDROME MARKET, BY DOSE, 2017– 2026 (USD MILLION)

TABLE 97 MEXICO DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017– 2026 (USD MILLION)

TABLE 98 MEXICO DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017– 2026 (USD MILLION)

TABLE 99 MEXICO DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017– 2026 (USD MILLION)

TABLE 100 MEXICO DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 101 MEXICO BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 102 MEXICO DRY EYE SYNDROME MARKET, BY END USER, 2017– 2026 (USD MILLION)

TABLE 103 MEXICO DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017– 2026 (USD MILLION)

TABLE 104 EUROPE DRY EYE SYNDROME MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 105 EUROPE DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 106 EUROPE TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 107 EUROPE DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 108 EUROPE LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 109 EUROPE SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 110 EUROPE DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 111 EUROPE DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 112 EUROPE DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 113 EUROPE DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 114 EUROPE DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 115 EUROPE DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 116 EUROPE BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 117 EUROPE DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 118 EUROPE DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 119 GERMANY DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 120 GERMANY TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 121 GERMANY DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 122 GERMANY LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 123 GERMANY SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 124 GERMANY DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 125 GERMANY DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 126 GERMANY DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 127 GERMANY DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 128 GERMANY DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 129 GERMANY DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 130 GERMANY BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 131 GERMANY DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 132 GERMANY DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 133 U.K. DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 134 U.K. TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 135 U.K. DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 136 U.K. LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 137 U.K. SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 138 U.K. DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 139 U.K. DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 140 U.K. DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 141 U.K. DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 142 U.K. DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 143 U.K. DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 144 U.K. BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 145 U.K. DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 146 U.K. DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 147 FRANCE DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 148 FRANCE TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 149 FRANCE DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 150 FRANCE LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 151 FRANCE SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 152 FRANCE DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 153 FRANCE DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 154 FRANCE DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 155 FRANCE DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 156 FRANCE DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 157 FRANCE DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 158 FRANCE BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 159 FRANCE DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 160 FRANCE DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 161 ITALY DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 162 ITALY TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 163 ITALY DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 164 ITALY LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 165 ITALY SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 166 ITALY DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 167 ITALY DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 168 ITALY DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 169 ITALY DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 170 ITALY DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 171 ITALY DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 172 ITALY BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 173 ITALY DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 174 ITALY DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 175 SPAIN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 176 SPAIN TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 177 SPAIN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 178 SPAIN LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 179 SPAIN SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 180 SPAIN DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 181 SPAIN DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 182 SPAIN DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 183 SPAIN DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 184 SPAIN DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 185 SPAIN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 186 SPAIN BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 187 SPAIN DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 188 SPAIN DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 189 RUSSIA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 190 RUSSIA TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 191 RUSSIA DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 192 RUSSIA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 193 RUSSIA SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 194 RUSSIA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 195 RUSSIA DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 196 RUSSIA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 197 RUSSIA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 198 RUSSIA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 199 RUSSIA DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 200 RUSSIA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 201 RUSSIA DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 202 RUSSIA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 203 NETHERLANDS DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 204 NETHERLANDS TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 205 NETHERLANDS DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 206 NETHERLANDS LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 207 NETHERLANDS SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 208 NETHERLANDS DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 209 NETHERLANDS DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 210 NETHERLANDS DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 211 NETHERLANDS DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 212 NETHERLANDS DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 213 NETHERLANDS DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 214 NETHERLANDS BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 215 NETHERLANDS DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 216 NETHERLANDS DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 217 SWITZERLAND DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 218 SWITZERLAND TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 219 SWITZERLAND DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 220 SWITZERLAND LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 221 SWITZERLAND SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 222 SWITZERLAND DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 223 SWITZERLAND DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 224 SWITZERLAND DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 225 SWITZERLAND DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 226 SWITZERLAND DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 227 SWITZERLAND DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 228 SWITZERLAND BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 229 SWITZERLAND DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 230 SWITZERLAND DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 231 BELGIUM DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 232 BELGIUM TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 233 BELGIUM DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 234 BELGIUM LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 235 BELGIUM SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 236 BELGIUM DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 237 BELGIUM DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 238 BELGIUM DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 239 BELGIUM DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 240 BELGIUM DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 241 BELGIUM DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 242 BELGIUM BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 243 BELGIUM DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 244 BELGIUM DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 245 TURKEY DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 246 TURKEY TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 247 TURKEY DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 248 TURKEY LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 249 TURKEY SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 250 TURKEY DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 251 TURKEY DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 252 TURKEY DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 253 TURKEY DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 254 TURKEY DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 255 TURKEY DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 256 TURKEY BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 257 TURKEY DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 258 TURKEY DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 259 REST OF EUROPE DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 260 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 261 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 262 ASIA-PACIFIC TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 263 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 264 ASIA-PACIFIC LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 265 ASIA-PACIFIC SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 266 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 267 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 268 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 269 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 270 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 271 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 272 ASIA-PACIFIC BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 273 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 274 ASIA-PACIFIC DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 275 JAPAN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 276 JAPAN TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 277 JAPAN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 278 JAPAN LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 279 JAPAN SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 280 JAPAN DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 281 JAPAN DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 282 JAPAN DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 283 JAPAN DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 284 JAPAN DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 285 JAPAN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 286 JAPAN BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 287 JAPAN DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 288 JAPAN DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 289 CHINA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 290 CHINA TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 291 CHINA DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 292 CHINA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 293 CHINA SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 294 CHINA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 295 CHINA DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 296 CHINA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 297 CHINA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 298 CHINA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 299 CHINA DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 300 CHINA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 301 CHINA DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 302 CHINA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 303 INDIA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 304 INDIA TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 305 INDIA DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 306 INDIA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 307 INDIA SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 308 INDIA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 309 INDIA DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 310 INDIA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 311 INDIA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 312 INDIA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 313 INDIA DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 314 INDIA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 315 INDIA DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 316 INDIA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 317 SOUTH KOREA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 318 SOUTH KOREA TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 319 SOUTH KOREA DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 320 SOUTH KOREA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 321 SOUTH KOREA SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 322 SOUTH KOREA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 323 SOUTH KOREA DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 324 SOUTH KOREA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 325 SOUTH KOREA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 326 SOUTH KOREA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 327 SOUTH KOREA DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 328 SOUTH KOREA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 329 SOUTH KOREA DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 330 SOUTH KOREA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 331 AUSTRALIA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 332 AUSTRALIA TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 333 AUSTRALIA DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 334 AUSTRALIA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 335 AUSTRALIA SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 336 AUSTRALIA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 337 AUSTRALIA DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 338 AUSTRALIA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 339 AUSTRALIA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 340 AUSTRALIA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 341 AUSTRALIA DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 342 AUSTRALIA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 343 AUSTRALIA DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 344 AUSTRALIA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 345 SINGAPORE DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 346 SINGAPORE TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 347 SINGAPORE DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 348 SINGAPORE LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 349 SINGAPORE SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 350 SINGAPORE DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 351 SINGAPORE DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 352 SINGAPORE DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 353 SINGAPORE DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 354 SINGAPORE DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 355 SINGAPORE DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 356 SINGAPORE BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 357 SINGAPORE DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 358 SINGAPORE DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 359 THAILAND DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 360 THAILAND TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 361 THAILAND DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 362 THAILAND LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 363 THAILAND SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 364 THAILAND DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 365 THAILAND DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 366 THAILAND DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 367 THAILAND DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 368 THAILAND DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 369 THAILAND DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 370 THAILAND BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 371 THAILAND DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 372 THAILAND DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 373 MALAYSIA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 374 MALAYSIA TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 375 MALAYSIA DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 376 MALAYSIA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 377 MALAYSIA SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 378 MALAYSIA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 379 MALAYSIA DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 380 MALAYSIA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 381 MALAYSIA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 382 MALAYSIA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 383 MALAYSIA DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 384 MALAYSIA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 385 MALAYSIA DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 386 MALAYSIA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 387 INDONESIA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 388 INDONESIA TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 389 INDONESIA DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 390 INDONESIA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 391 INDONESIA SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 392 INDONESIA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 393 INDONESIA DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 394 INDONESIA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 395 INDONESIA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 396 INDONESIA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 397 INDONESIA DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 398 INDONESIA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 399 INDONESIA DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 400 INDONESIA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 401 PHILIPPINES DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 402 PHILIPPINES TEAR STIMULATORS IN DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

TABLE 403 PHILIPPINES DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 404 PHILIPPINES LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 405 PHILIPPINES SEMI SOLID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017-2026 (USD MILLION)

TABLE 406 PHILIPPINES DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017-2026 (USD MILLION)

TABLE 407 PHILIPPINES DRY EYE SYNDROME MARKET, BY DOSE, 2017-2026 (USD MILLION)

TABLE 408 PHILIPPINES DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017-2026 (USD MILLION)

TABLE 409 PHILIPPINES DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017-2026 (USD MILLION)

TABLE 410 PHILIPPINES DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017-2026 (USD MILLION)

TABLE 411 PHILIPPINES DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 412 PHILIPPINES BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 413 PHILIPPINES DRY EYE SYNDROME MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 414 PHILIPPINES DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 415 REST OF APAC DRY EYE SYNDROME MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 416 SOUTH AMERICA DRY EYE SYNDROME MARKET, BY COUNTRY, 2017– 2026 (USD MILLION)

TABLE 417 SOUTH AMERICA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 418 SOUTH AMERICA TEAR STIMULATORS MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 419 SOUTH AMERICA TEAR STIMULATORS MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 420 SOUTH AMERICA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 421 SOUTH AMERICA SEMI-SOLIDS IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 422 SOUTH AMERICA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017– 2026 (USD MILLION)

TABLE 423 SOUTH AMERICA DRY EYE SYNDROME MARKET, BY DOSE, 2017– 2026 (USD MILLION)

TABLE 424 SOUTH AMERICA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017– 2026 (USD MILLION)

TABLE 425 SOUTH AMERICA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017– 2026 (USD MILLION)

TABLE 426 SOUTH AMERICA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017– 2026 (USD MILLION)

TABLE 427 SOUTH AMERICA DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 428 SOUTH AMERICA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 429 SOUTH AMERICA DRY EYE SYNDROME MARKET, BY END USER, 2017– 2026 (USD MILLION)

TABLE 430 SOUTH AMERICA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017– 2026 (USD MILLION)

TABLE 431 BRAZIL DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 432 BRAZIL TEAR STIMULATORS MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 433 BRAZIL TEAR STIMULATORS MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 434 BRAZIL LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 435 BRAZIL SEMI-SOLIDS IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 436 BRAZIL DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017– 2026 (USD MILLION)

TABLE 437 BRAZIL DRY EYE SYNDROME MARKET, BY DOSE, 2017– 2026 (USD MILLION)

TABLE 438 BRAZIL DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017– 2026 (USD MILLION)

TABLE 439 BRAZIL DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017– 2026 (USD MILLION)

TABLE 440 BRAZIL DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017– 2026 (USD MILLION)

TABLE 441 BRAZIL DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 442 BRAZIL BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 443 BRAZIL DRY EYE SYNDROME MARKET, BY END USER, 2017– 2026 (USD MILLION)

TABLE 444 BRAZIL DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017– 2026 (USD MILLION)

TABLE 445 REST OF SOUTH AMERICA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 446 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY COUNTRY, 2017– 2026 (USD MILLION)

TABLE 447 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 448 MIDDLE EAST AND AFRICA TEAR STIMULATORS MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 449 MIDDLE EAST AND AFRICA TEAR STIMULATORS MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 450 MIDDLE EAST AND AFRICA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 451 MIDDLE EAST AND AFRICA SEMI-SOLIDS IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 452 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017– 2026 (USD MILLION)

TABLE 453 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY DOSE, 2017– 2026 (USD MILLION)

TABLE 454 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017– 2026 (USD MILLION)

TABLE 455 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017– 2026 (USD MILLION)

TABLE 456 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017– 2026 (USD MILLION)

TABLE 457 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 458 MIDDLE EAST AND AFRICA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 459 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY END USER, 2017– 2026 (USD MILLION)

TABLE 460 MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017– 2026 (USD MILLION)

TABLE 461 SOUTH AFRICA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 462 SOUTH AFRICA TEAR STIMULATORS MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

TABLE 463 SOUTH AFRICA TREATMENT MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 464 SUTH AMERICA LIQUID IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 465 SOUTH AFRICA SEMI-SOLIDS IN DRY EYE SYNDROME MARKET, BY DOSAGE TYPE, 2017– 2026 (USD MILLION)

TABLE 466 SOUTH AFRICA DRY EYE SYNDROME MARKET, BY DRUG CLASS, 2017– 2026 (USD MILLION)

TABLE 467 SOUTH AFRICA DRY EYE SYNDROME MARKET, BY DOSE, 2017– 2026 (USD MILLION)

TABLE 468 SOUTH AFRICA DRY EYE SYNDROME MARKET, BY MEDICATION TYPE, 2017– 2026 (USD MILLION)

TABLE 469 SOUTH AFRICA DRY EYE SYNDROME MARKET, BY CONTAINER TYPE, 2017– 2026 (USD MILLION)

TABLE 470 SOUTH AFRICA DRY EYE SYNDROME MARKET, BY PACKAGING TYPE, 2017– 2026 (USD MILLION)

TABLE 471 SOUTH AFRICA DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 472 SOUTH AFRICA BRANDS IN DRY EYE SYNDROME MARKET, BY TYPE, 2017– 2026 (USD MILLION)

TABLE 473 SOUTH AFRICA DRY EYE SYNDROME MARKET, BY END USER, 2017– 2026 (USD MILLION)

TABLE 474 SOUTH AFRICA DRY EYE SYNDROME MARKET, BY DISTRIBUTION CHANNEL, 2017– 2026 (USD MILLION)

TABLE 475 REST OF MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET, BY PRODUCT TYPE, 2017– 2026 (USD MILLION)

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19